3,3',5-triiodothyroacetic acid has been researched along with Psoriasis in 1 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "TriAc in the dosage and formulation studied was safe but no more effective than placebo in treating plaque psoriasis." | 2.71 | Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial. ( Carlsson, B; Törmä, H; Vahlquist, A, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vahlquist, A | 1 |
| Törmä, H | 1 |
| Carlsson, B | 1 |
1 trial available for 3,3',5-triiodothyroacetic acid and Psoriasis
| Article | Year |
|---|---|
Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
Topics: Administration, Topical; Adult; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Midd | 2004 |